Online mindfulness program to help prevent relapse in people recovering from substance use.
Official title: Web-Based Mindfulness Treatment to Prevent Relapse to Substance Use
Funded at Yale University · NIH-10900567 · Data updated 2026-11-12
This study is looking at how a web-based mindfulness program can help people recovering from substance use disorders stay on track and avoid relapse by making mindfulness practices easier to access and understand.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | August 1, 2020 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $164,683 |
| NIH project number | 5K23AT011342-05 |
| Project ID | NIH-10900567 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals who have recently completed intensive treatment for substance use disorders and are seeking aftercare support.
✕Less likely to help
Patients who are not in recovery from substance use disorders or those who have not undergone any form of treatment may not benefit from this research.
What this research studies
This research investigates the effectiveness of a web-based mindfulness treatment designed to support individuals recovering from substance use disorders (SUD) and prevent relapse. It aims to make mindfulness practices more accessible through technology, addressing the barriers that limit traditional aftercare options. By utilizing ecological momentary assessment (EMA), the study will gather real-time data on participants' emotional states, cravings, and stress levels to understand how mindfulness can help manage these factors. The goal is to identify the mechanisms that make mindfulness effective in reducing relapse rates.
Why it matters
Potential benefit: If successful, this research could provide a scalable and accessible tool for individuals in recovery, significantly reducing the likelihood of relapse.
How similar studies have gone: While mindfulness treatment has shown promise in other contexts, this specific approach using web-based technology and EMA for SUD is relatively novel and untested.
Where this research is happening
-
Yale University
New Haven, United States Active
Researchers
- Principal investigator: Roos, Corey — Yale University
- Study coordinator: Roos, Corey
Related research
Other NIH-funded projects on the same topics.
-
Mindfulness-Based Relapse Prevention via Video Calls for Long-Term Recovery from Alcohol Use Disorder
A funded program tests video-delivered mindfulness-based relapse prevention to support adults with alcohol use disorder in achieving long-term recovery.
-
Clinical decision support to spot relapse risk early in teens with substance use disorders
A new tool called LEVL helps clinicians spot early signs that a teen recovering from substance use might relapse, so they can intervene sooner.
-
Video mindfulness program to support long-term recovery from alcohol use
This offers live video mindfulness sessions as continuing care for adults with alcohol use disorder to help reduce heavy drinking and support recovery.
-
Using mindfulness to help prevent relapse in alcohol use disorder
This study is looking at how mindfulness practices can help people with alcohol use disorder stay on track and avoid relapse, using wearable sensors to see how these practices affect their feelings and cravings in real time.
-
Using mindfulness to help people reduce alcohol use through online support
This study is exploring how online mindfulness sessions can help people with alcohol use issues by offering support and strategies to cut back on drinking and feel better overall, making it easier for more folks to join in on their recovery journey.
-
Developing a new medication to help prevent relapse in methamphetamine users
This study is testing a new medication called MT-110 to help people with methamphetamine use disorder stay off the drug and avoid relapse, since there aren't any approved treatments available right now.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.